Cardio Vascular Diseases or CVD is the worldÕs leading cause of death in men and women and these deaths are due to heart failure, congenital heart disease, peripheral vascular disease, cardiomyopathy, coronary heart disease and stroke. Cardio vascular monitoring devices help in identifying electrical and pressure waveforms of the cardiovascular system for the treatment and measurement of cardio vascular diseases. Nowadays, new emerging non-invasive cardiovascular monitoring technologies are playing very important role in treatment therapies of cardio vascular diseases. This long term non-invasive cardiovascular monitoring has important prognostic applications and provides accurate information for cardiovascular treatment and diagnosis. Cardio vascular diagnosis tests include cardiac catheterization, blood tests, cardiac magnetic resonance imaging (MRI), electrocardiogram, cardiac computerized tomography (CT) scan and echocardiogram.
Scope of the Report:This report focuses on the Cardiovascular Disease Monitoring and Diagnostic Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
With largest market share of around 38%, North America cardiovascular monitoring and diagnostic devices market is growing rapidly and it is expected to grow at CAGR of around 5.6% in the coming years. Europe is second largest market followed by Asia Pacific region for cardiovascular monitoring and diagnostic devices market. Europe is predicted to grow at healthy growth rate in forecast period with emerging advanced technologies in monitoring and diagnosis of cardiovascular diseases.
The worldwide market for Cardiovascular Disease Monitoring and Diagnostic Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2026, from xx million US$ in 2020, according to a new study.
Market Segment by Manufacturers, this report covers Siemens
Bioanalytical Systems_Inc
Ge Healthcare
Philips Healthcare
Mortara Instrument, Inc
Spacelabs Healthcare Inc.
Schiller AG
Welch Allyn
Mindray Medical International Limited
Compumed Inc.
Cardionet Inc.
Gehealthcare
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers ECG Systems
Event Monitors
Holter Monitors
Implantable Loop Recorders
ECG Management Systems
Market Segment by Applications, can be divided into Heart Disease
Coronary Heart Disease
There are 15 Chapters to deeply display the global Cardiovascular Disease Monitoring and Diagnostic Devices market.
Chapter 1, to describe Cardiovascular Disease Monitoring and Diagnostic Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiovascular Disease Monitoring and Diagnostic Devices, with sales, revenue, and price of Cardiovascular Disease Monitoring and Diagnostic Devices, in 2018 and 2019;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2018 and 2019;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiovascular Disease Monitoring and Diagnostic Devices, for each region, from 2015 to 2020;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2015 to 2020;
Chapter 12, Cardiovascular Disease Monitoring and Diagnostic Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2026;
Chapter 13, 14 and 15, to describe Cardiovascular Disease Monitoring and Diagnostic Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
